Research Symposia

For times, rooms, and speakers, visit the Online Program Planner (available in January).

Key: The number in parentheses is the session number; the R denotes a research session.

March 25

  • Are GAD and MDD Distinct?: Utilizing Laboratory Methodologies to Address Diagnostic Convergence and Divergence (326R)
  • Current Advances in Treatments for Pediatric OCD (327R)
  • Deconstructing Social Anxiety: From Basic Concepts to Complex Behaviors (328R)
  • Emerging Resources for the Prevention, Treatment, and Identification of Underserved Youth at Risk for Anxiety Disorders (329R)
  • Dimensions of Psychopathology: Implications for Treatment and Research in Anxiety Disorders (331R)
  • Novel Screening, Assessment, and Treatment Techniques: Canadian Research on Early Internalizing Disorders (334R)
  • Psychophysiologic Reactivity at Rest and in Response to Simulated Stressors in OEF/OIF Veterans (337R)
  • Risk Factors for Adverse Mental Health Outcomes in Military Veterans Affected by Hurricane Katrina (339R)
  • Treatment Interference in OCD and Other Anxiety Disorders: The Role of Personality Traits, Family Accommodations, and Symptom Subtypes (355R)
  • Cognitive Behavioral Therapy vs. Acceptance and Commitment Therapy for Social Anxiety: Moderators and Mediators of Treatment Outcomes (364R)
  • Genetic Approaches to Understanding Anxiety-Spectrum Disorders (378R)

March 26

  • Advances in Posttraumatic Stress Disorder Among Maltreated Youth (324R)
  • Advancing the Applications and Boundaries of Traumatic Stress Research: Translation Between Empirical Inquiry and Clinical Case Findings (325R)
  • Neurobiological and Psychological Sequelae of Childhood Trauma (332R)
  • New Developments in the Conceptualization and Cognitive Behavioral Therapy of Obsessive-Compulsive Spectrum Disorders (333R)
  • Patients, Primary Care, and Policies : A View From Across the Pond (336R)
  • Translational Methods in Anxiety Disorders Research: From Animals to Humans and Back Again (340R)
  • Understudied Aspects of Social Anxiety: Empirical Investigations of Malleable Underlying Mechanisms and their Implications for Treatment (341R)
  • Update on Body Dysmorphic Disorder: Research Findings and Treatment Approaches (342R)
  • Ten Years After 9/11: Course of Symptoms and Response to Treatments (343R)
  • Mediators of the Relationship Between Anxiety Sensitivity and Problem Drinking (345R)
  • The Calm Study: Cost, Pain, Medical Illness, and Alternative Medicine (347R)
  • Examining the “Black Box”: In-Session Processes of Change in Psychotherapy (Prolonged Exposure) and Pharmacotherapy (Sertraline) in Chronic PTSD (353R)
  • Complicated Bereavement in Cross-Cultural Perspective (354R) ***Read the related article Informing the symptom profile of complicated grief in the February issue of Depression and Anxiety.***
  • Prolonged Exposure (PE) Therapy for PTSD: Investigating Current Practices and Future Directions for Dissemination (356R)
  • Risk Factors and Predictors of Outcome for Geriatric Anxiety (358R)
  • Cultural Variations in the Clinical Presentations of Anxiety Disorders: Implications for Psychiatric Nosology and Treatment Adaptation for Ethnic Minorities (360R)
  • Delivering CBT on the Internet for Anxiety Problems: How Does It Work? (361R)
  • Anxiety Around the Globe: From Phenomenology to Treatment Dissemination (363R)
  • Moderators of CALM; Engagement, Age, Ethnicity, and Beliefs (369R)
  • Insider Tips: Publication Strategies Panel (371R)
  • Advances in the Biology and Treatment of PTSD (375R)

March 27

  • Extinction Learning as an Analogue for Exposure Therapy: Implications for the Treatment of Anxiety Disorders (330R)
  • Recent Innovations in the PTSD Treatment Research (338R)
  • The Psychological Hazards of High-Risk Occupations: Which Soldiers and Firefighters Are at Risk for PTSD and Its Associated Problems? (349R)
  • Anxiety Disorders Research in African Americans: New Directions From Early Career Researchers (351R)
  • Comorbid Attention-Deficit/Hyperactivity Disorder (ADHD) and Anxiety in Children: Recent Advances in Basic Research, Assessment, and Treatment (370R)

 

Contact ADAA

8701 Georgia Ave. #412
Silver Spring, MD 20910

240.485.1001

Contact ADAA

Request Publications

FacebookTwitterRSS

 

ADAA is a national nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, OCD, PTSD, depression, and related disorders and to improving the lives of all people who suffer from them.

 

Health Impact Award

Award for Excellence


Independent Charities of America